Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

GI03-53

A Phase II Trial of Preoperative Capecitabine Plus Irinotecan Followed by Combined Modality Capecitabine and Radiation for Locally Advanced Rectal Cancer – GI03-53

Abstracts/Posters/Presentations:

  • Chiorean EG, Schiel M, Sanghani S, Yu M, Shen J, Cardenes H, LeBlanc J, Robb B, Loehrer PJ, Harvey J: A Phase II trial of Neoadjuvant Capecitabine plus Irinotecan Followed by Combined Modality Capecitabine and Radiation Therapy for Patients with Locally Advanced Rectal Cancer: Hoosier Oncology Group GI03-53. Accepted as Poster Presentation at the ASCO GI Symposium, January 25-27, 2008, Orlando, FL
  • Chiorean EG, Schiel M, Sanghani S, Yu M, Shen J, Cardenes H, LeBlanc J, Robb B, Loehrer PJ, Harvey J: A Phase II trial of Neoadjuvant Capecitabine plus Irinotecan Followed by Combined Modality Capecitabine and Radiation Therapy for Patients with Locally Advanced Rectal Cancer: Hoosier Oncology Group GI03-53. Poster Presentation at Indiana University Melvin and Bren Simon Cancer Center Cancer Research Day, May 7, 2008

Manuscripts/Articles:

  • Cardenes, H., Sanghani, S., Burns, M., Robb, B., Hinkle, D., Johnson, C., Yu, M., Currie, C., Loehrer, P., Chiorean, E. Phase II Trial of Neoadjuvant Capecitabine (Cp) with Irinotecan (Ir) followed by Capecitabine-based Chemoradiotherapy (CRT) for Patients (pts) with Locally Advanced Rectal Cancer (LARC): A Hoosier Oncology Group Study GI03-53. International Journal of Radiation Oncology*Biology*Physics. Volume 78, Issue 3, Supplement, Page S54, 1 November 2010. doi:10.1016/j.ijrobp.2010.07.160